ABCDx

ABCDx

Transforming brain injury care by the use of biomarker panel tests for the assessment and indication in patients. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout

N/A

Grant
N/A

N/A

Seed

N/A

Early VC
*

€2.8m

Grant
Total FundingAUD4.7m

Recent News about ABCDx

Edit
More about ABCDx
Edit

Developer of a compact medical device created to diagnose a mild traumatic brain injury. The company's device analyzes the level of proteins in the blood using a single drop of blood to diagnose the probability of a mild traumatic brain injury within ten minutes, enabling healthcare professionals to early detection of brain injuries, quick clinical decision-making and significantly lower expense for the majority of patients.

Keywords: Healthcare Devices, Services, Supplies, Blood-Based Biomarker, Blood-Based Biomarker Test, Brain Biomarker, Brain Biomarkers, Brain Injury Detection, Traumatic Brain.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.